Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double-Blind, Placebo-controlled Study of Suramin in Subjects With Furosemide-Resistant Acute Kidney Injury (AKI): Efficacy in Preventing Dialysis Dependent AKI

NCT04496596 is registered in ClinicalTrials.gov with Rediscovery Life Sciences as lead sponsor.

NCT NCT04496596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04496596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double-Blind, Placebo-controlled Study of Suramin in Subjects With Furosemide-Resistant Acute Kidney Injury (AKI): Efficacy in Preventing Dialysis Dependent AKI
Lead sponsor
Rediscovery Life Sciences
Phase
Phase 2
Overall status
Unknown status
Start date
November 13, 2020
Completion date
December 22, 2023
Enrollment
68 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury